Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-14T15:19:26.144Z Has data issue: false hasContentIssue false

Section 6 - Length-Dependent Polyneuropathies

Published online by Cambridge University Press:  20 April 2018

Mark B. Bromberg
Mark B. Bromberg
Affiliation:
University of Utah
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Peripheral Neuropathies
A Practical Approach
 , pp. 135 - 172
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Allen, JA, Lewis, RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology. 2015;85:498–504.CrossRefGoogle ScholarPubMed
Cashman, CR, Hoke, A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett. 2015;596:33–50.CrossRefGoogle ScholarPubMed
Perkins, B, Bril, V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol. 2014;126:235–48.CrossRefGoogle ScholarPubMed

References

Bril, V, Blanchette, CM, Noone, JM, Runken, MC, Gelinas, D, Russell, JW. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications. 2016;30:1401–7.Google Scholar
Bromberg, MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991;14(10):968–76.Google Scholar
Callaghan, BC, Little, AA, Feldman, EL, Hughes, RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012:CD007543.Google ScholarPubMed
de Souza, RJ, de Souza, A, Nagvekar, MD. Nerve conduction studies in diabetics presymptomatic and symptomatic for diabetic polyneuropathy. J Diabetes Complications. 2015;29:811–17.Google Scholar
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.Google Scholar
England, JD, Gronseth, GS, Franklin, G, Carter, GT, Kinsella, LJ, Cohen, JA, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185–92.Google Scholar
Gibbons, CH, Freeman, R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.CrossRefGoogle ScholarPubMed
Kennedy, WR, Navarro, X, Goetz, FC, Sutherland, DE, Najarian, JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990;322:1031–7.CrossRefGoogle ScholarPubMed
Lotan, I, Hellman, MA, Steiner, I. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Acta Neurol Scand. 2015;132:278–83.CrossRefGoogle ScholarPubMed
Pan, H, Jian, F, Lin, J, Chen, N, Zhang, C, Zhang, Z, et al. F-wave latencies in patients with diabetes mellitus. Muscle Nerve. 2014;49:804–8.CrossRefGoogle ScholarPubMed
Singleton, JR, Smith, AG, Bromberg, MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001;24:1448–53.CrossRefGoogle ScholarPubMed
Singleton, JR, Smith, AG, Marcus, RL. Exercise as Therapy for Diabetic and Prediabetic Neuropathy. Curr Diab Rep. 2015;15:120.CrossRefGoogle ScholarPubMed
Smith, AG, Singleton, JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications. 2013;27:436–42.Google Scholar
Sommer, C. Skin biopsy as a diagnostic tool. Curr Opin Neurol. 2008;21:563–8.CrossRefGoogle ScholarPubMed

References

Kumar, SK, Gertz, MA, Lacy, MQ, Dingli, D, Hayman, SR, Buadi, FK, et al. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc. 2011;86:12–18.Google Scholar
Matsuda, M, Gono, T, Morita, H, Katoh, N, Kodaira, M, Ikeda, S. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. European journal of neurology. 2011;18:604–10.Google Scholar
Rajabally, YA. Neuropathy and paraproteins: review of a complex association. European journal of neurology. 2011;18:1291–8.Google Scholar
Shin, SC, Robinson-Papp, J. Amyloid neuropathies. Mt Sinai J Med. 2012;79:733–48.Google Scholar

References

Koffman, BM, Greenfield, LJ, Ali, LL, Pirzada, NA. Neurologic complications after surgery for obesity. Muscle Nerve. 2006;33:166–76.CrossRefGoogle ScholarPubMed
Rudnicki, SA. Prevention and treatment of peripheral neuropathy after bariatric surgery. Curr Treat Options Neurol. 2010;12:29–36.Google Scholar
Thaisetthawatkul, P, Collazo-Clavell, ML, Sarr, MG, Norell, JE, Dyck, PJ. A controlled study of peripheral neuropathy after bariatric surgery. Neurology. 2004;63:1462–70.Google Scholar
Thaisetthawatkul, P, Collazo-Clavell, ML, Sarr, MG, Norell, JE, Dyck, PJ. Good nutritional control may prevent polyneuropathy after bariatric surgery. Muscle Nerve. 2010;42:709–14.Google Scholar

References

Bolton, CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32:140–63.CrossRefGoogle ScholarPubMed
Goodman, BP, Harper, CM, Boon, AJ. Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve. 2009;40:1040–2.Google Scholar
Khan, J, Harrison, TB, Rich, MM, Moss, M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67:1421–5.Google Scholar
Lacomis, D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve. 2013;47:452–63.Google Scholar

References

Donofrio, PD, Wilbourn, AJ, Albers, JW, Rogers, L, Salanga, V, Greenberg, HS. Acute arsenic intoxication presenting as Guillain-Barre-like syndrome. Muscle Nerve. 1987;10:114–20.CrossRefGoogle ScholarPubMed
Koike, H, Mori, K, Misu, K, Hattori, N, Ito, H, Hirayama, M, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology. 2001;56:1727–32.Google Scholar
Mellion, M, Gilchrist, JM, de la Monte, S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve. 2011;43:309–16.Google Scholar
Oh, SJ. Lead neuropathy: case report. Arch Phys Med Rehabil. 1975;56:312–17.Google Scholar
Thomson, RM, Parry, GJ. Neuropathies associated with excessive exposure to lead. Muscle Nerve. 2006;33:732–41.Google Scholar
Vahidnia, A, van der Voet, GB, de Wolff, FA. Arsenic neurotoxicity – a review. Hum Exp Toxicol. 2007;26:823–32.CrossRefGoogle ScholarPubMed
Wu, PB, Kingery, WS, Date, ES. An EMG case report of lead neuropathy 19 years after a shotgun injury. Muscle Nerve. 1995;18:326–9.CrossRefGoogle Scholar

References

Albin, RL, Albers, JW, Greenberg, HS, Townsend, JB, Lynn, RB, Burke, JM, Jr., et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology. 1987;37:1729–32.Google Scholar
Berger, AR, Schaumburg, HH, Schroeder, C, Apfel, S, Reynolds, R. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42:1367–70.CrossRefGoogle ScholarPubMed
Cavaletti, G, Beronio, A, Reni, L, Ghiglione, E, Schenone, A, Briani, C, et al. Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology. 2004;62:2291–3.CrossRefGoogle ScholarPubMed
Cavaletti, G, Nobile-Orazio, E. Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica. 2007;92:1308–10.CrossRefGoogle ScholarPubMed
Chaudhry, V, Chaudhry, M, Crawford, TO, Simmons-O’Brien, E, Griffin, JW. Toxic neuropathy in patients with pre-existing neuropathy. Neurology. 2003;60:337–40.Google Scholar
Chaudhry, V, Cornblath, DR, Corse, A, Freimer, M, Simmons-O’Brien, E, Vogelsang, G. Thalidomide-induced neuropathy. Neurology. 2002;59:1872–5.CrossRefGoogle ScholarPubMed
DeAngelis, LM, Gnecco, C, Taylor, L, Warrell, RP, Jr. Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin’s lymphoma. Cancer. 1991;67:2241–6.Google Scholar
Fraser, AG, McQueen, IN, Watt, AH, Stephens, MR. Peripheral neuropathy during longterm high-dose amiodarone therapy. J Neurol Neurosurg Psychiatry. 1985;48:576–8.Google Scholar
Freilich, RJ, Balmaceda, C, Seidman, AD, Rubin, M, DeAngelis, LM. Motor neuropathy due to docetaxel and paclitaxel. Neurology. 1996;47:115–18.Google Scholar
Ghavanini, AA, Kimpinski, K. Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess. J Clin Neuromuscul Dis. 2014;16:25–31.Google Scholar
Kammire, LD, Donofrio PD. Nitrofurantoin neuropathy: a forgotten adverse effect. Obstet Gynecol. 2007;110:510–12.CrossRefGoogle ScholarPubMed
Kranick, SM, Nath, A. Neurologic complications of HIV-1 infection and its treatment in the ear of antiretroviral therapy. Continuum (Minnea; Minn). 2012;13:319–37.Google Scholar
Kuncl, RW, Duncan, G, Watson, D, Alderson, K, Rogawski, MA, Peper, M. Colchicine myopathy and neuropathy. N Engl J Med. 1987;316:1562–8.Google Scholar
Manji, H. Drug-induced neuropathies. Handb Clin Neurol. 2013;115:729–42.Google Scholar
Margolis, AM, Heverling, H, Pham, PA, Stolbach, A. A review of toxicity of HIV medications. J Med Toxicol. 2014; 10:26-39.Google Scholar
Morawska, M, Grzasko, N, Kostyra, M, Wojciechowicz, J, Hus, M. Therapy-related peripheral neuropathy in multiple myeloma patients. Hematol Oncol. 2015;33:113–19.CrossRefGoogle ScholarPubMed
Nath, A. Neurologic comlications of human immunodeficiency virus infection. Continuum (Minnea; Minn). 2015; 21:1557–76.Google Scholar
Orr, CF, Ahlskog, JE. Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol. 2009;66:865–9.CrossRefGoogle ScholarPubMed
Parry, GJ, Bredesen, DE. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985;35:1466–8.Google Scholar
Schaumburg, H, Kaplan, J, Windebank, A, Vick, N, Rasmus, S, Pleasure, D, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983;309:445–8.CrossRefGoogle ScholarPubMed
Taieb, S, Trillet-Lenoir, V, Rambaud, L, Descos, L, Freyer, G. Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patients. Cancer. 2002;94:2434–40.Google Scholar
Tan, IL, Polydefkis, MJ, Ebenezer, GJ, Hauer, P, McArthur, JC. Peripheral nerve toxic effects of nitrofurantoin. Arch Neurol. 2012;69:265–8.Google Scholar
Thawani, SP, Tanji, K, De Sousa, EA, Weimer, LH, Brannagan, TH, III. Bortezomib-associated demyelinating neuropathy – clinical and pathologic features. J Clin Neuromuscul Dis. 2015;16:202–209.Google Scholar
Windebank, AJ, Grisold, W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13:27–46.Google Scholar

References

Amruth, G, Praveen-kumar, S, Nataraju, B, Nagaraja, BS. HIV Associated Sensory Neuropathy. J Clin Diagn Res. 2014;8:MC04–7.Google Scholar
Cashman, CR, Hoke, A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett. 2015;596:33–50.Google Scholar
Lee, AJ, Bosch, RJ, Evans, SR, Wu, K, Harrison, T, Grant, P, et al. Patterns of peripheral neuropathy in ART-naive patients initiating modern ART regimen. J Neurovirol. 2015;21:210–18.CrossRefGoogle ScholarPubMed
Phillips, TJ, Cherry, CL, Cox, S, Marshall, SJ, Rice, AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One. 2010;5:e14433.Google Scholar
Robinson-Papp, J, Sharma, S, Dhadwal, N, Simpson, DM, Morgello, S. Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015;51:56–64.Google Scholar
Schutz, SG, Robinson-Papp, J. HIV-related neuropathy: current perspectives. HIV AIDS (Auckl). 2013;5:243–51.Google Scholar
Wulff, EA, Wang, AK, Simpson, DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000;59:1251–60.Google Scholar

References

de Freitas, MR, Said, G. Leprous neuropathy. Handb Clin Neurol. 2013;115:499–514.Google Scholar
Jain, S, Visser, LH, Suneetha, S. Imaging techniques in leprosy clinics. Clin Dermatol. 2016;34:70–8.CrossRefGoogle ScholarPubMed
Nations, SP, Katz, JS, Lyde, CB, Barohn, RJ. Leprous neuropathy: an American perspective. Semin Neurol. 1998;18:113–24.CrossRefGoogle ScholarPubMed
Payne, R, Baccon, J, Dossett, J, Scollard, D, Byler, D, Patel, A, et al. Pure neuritic leprosy presenting as ulnar nerve neuropathy: a case report of electrodiagnostic, radiographic, and histopathological findings. J Neurosurg. 2015;123:1238–43.CrossRefGoogle ScholarPubMed

References

Botez, MI, Peyronnard, JM, Bachevalier, J, Charron, L. Polyneuropathy and folate deficiency. Arch Neurol. 1978;35:581–4.Google Scholar
Dalla Torre, C, Lucchetta, M, Cacciavillani, M, Campagnolo, M, Manara, R, Briani, C. Reversible isolated sensory axonal neuropathy due to cobalamin deficiency. Muscle Nerve. 2012;45:428–30.Google ScholarPubMed
Koike, H, Takahashi, M, Ohyama, K, Hashimoto, R, Kawagashira, Y, Iijima, M, et al. Clinicopathologic features of folate-deficiency neuropathy. Neurology. 2015;84:1026–33.Google Scholar
Kumar, N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–26.Google Scholar
Saperstein, DS, Barohn, RJ. Peripheral Neuropathy Due to Cobalamin Deficiency. Curr Treat Options Neurol. 2002;4:197–201.Google Scholar

References

Giometto, B, Grisold, W, Vitaliani, R, Graus, F, Honnorat, J, Bertolini, G. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67:330–5.Google Scholar
Giometto, B, Vitaliani, R, Lindeck-Pozza, E, Grisold, W, Vedeler, C. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev. 2012;12:CD007625.Google Scholar
Graus, F, Delattre, JY, Antoine, JC, Dalmau, J, Giometto, B, Grisold, W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40.Google Scholar
Gwathmey, KG. Sensory neuronopathies. Muscle Nerve. 2016;53:8–19.Google Scholar
Koike, H, Sobue, G. Paraneoplastic neuropathy. Handb Clin Neurol. 2013;115:713–26.Google Scholar
Muppidi, S, Vernino, S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014;20:1359–72.Google Scholar

References

Chan, AC, Wilder-Smith, EP. Small fiber neuropathy: Getting bigger! Muscle Nerve. 2016;53:671–82.Google Scholar
Hoeijmakers, JG, Faber, CG, Merkies, IS, Waxman, SG. Painful peripheral neuropathy and sodium channel mutations. Neurosci Lett. 2015;596:51–9.CrossRefGoogle ScholarPubMed

References

Bolton, CF. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology. 1976;26:152–61.Google Scholar
Krishnan, AV, Kiernan, MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve. 2007;35:273–90.CrossRefGoogle ScholarPubMed
Ogura, T, Makinodan, A, Kubo, T, Hayashida, T, Hirasawa, Y. Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad Med J. 2001;77:451–4.Google Scholar
Ropper, AH. Accelerated neuropathy of renal failure. Arch Neurol. 1993;50:536–9.CrossRefGoogle ScholarPubMed
Said, G. Uremic neuropathy. Handb Clin Neurol. 2013;115:607–12.Google Scholar
Said, G, Boudier, L, Selva, J, Zingraff, J, Drueke, T. Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology. 1983;33:567–74.Google Scholar

References

Aziz, I, Hadjivassiliou, M, Sanders, DS. The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol. 2015; 12(9):516–26.Google Scholar
Farhad, K, Traub, R, Ruzhansky, KM, Brannagan, TH, III. Causes of neuropathy in patients referred as “idiopathic neuropathy.” Muscle Nerve. 2016; 53(6):856–61.CrossRefGoogle ScholarPubMed
Hadjivassiliou, M, Duker, AP, Sanders, DS. Gluten-related neurologic dysfunction. Handb Clin Neurol. 2014; 120:607–19.Google Scholar
Hadjivassiliou, M, Kandler, RH, Chattopadhyay, AK, Davies-Jones, AG, Jarratt, JA, Sanders, DS, et al. Dietary treatment of gluten neuropathy. Muscle Nerve. 2006; 34(6):762–6.CrossRefGoogle ScholarPubMed
Hadjivassiliou, M, Rao, DG, Grinewald, RA, Aeschlimann, DP, Sarrigiannis, PG, Hoggard, N, et al. Neurological Dysfunction in Coeliac Disease and Non-Coeliac Gluten Sensitivity. Am J Gastroenterol. 2016; 111(4):561–7.Google Scholar
Rashid, M, Lee, J. Serologic testing in celiac disease: Practical guide for clinicians. Can Fam Physician. 2016; 62(1):38–43.Google Scholar
Thawani, SP, Brannagan, TH, III, Lebwohl, B, Green, PH, Ludvigsson, JF. Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease. JAMA Neurol. 2015; 72(7):806–11.CrossRefGoogle Scholar

References

Halperin, JJ, Shapiro, ED, Logigian, E, Belman, AL, Dotevall, L, Wormser, GP, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91–102.Google Scholar
Hansen, K, Crone, C, Kristoferitsch, W. Lyme neuroborreliosis. Handb Clin Neurol. 2013;115:559–75.Google Scholar
Logigian, EL, Steere, AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology. 1992;42:303–11.Google Scholar
Moore, A, Nelson, C, Molins, C, Mead, P, Schriefer, M. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States. Emerging Infectious Diseases. 2016;10:1169–77.Google Scholar
Pachner, AR, Steiner, I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007;6:544–52.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×